GLAUKOS CORP (GKOS) Stock Fundamental Analysis
USA - NYSE:GKOS - US3773221029 - Common Stock
81.79 USD
-2.56 (-3.03%)
81.79 USD
0 (0%)
Taking everything into account, GKOS scores 4 out of 10 in our fundamental rating. GKOS was compared to 189 industry peers in the Health Care Equipment & Supplies industry. GKOS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GKOS is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
GKOS had negative earnings in the past year.
In the past year GKOS has reported a negative cash flow from operations.
In the past 5 years GKOS always reported negative net income.
GKOS had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of GKOS (-9.40%) is better than 61.90% of its industry peers.
GKOS has a Return On Equity of -12.13%. This is in the better half of the industry: GKOS outperforms 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.4% | ||
| ROE | -12.13% | ||
| ROIC | N/A |
ROA(3y)-13.08%
ROA(5y)-11.18%
ROE(3y)-22.32%
ROE(5y)-18.69%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GKOS has a better Gross Margin (76.34%) than 88.36% of its industry peers.
GKOS's Gross Margin has declined in the last couple of years.
GKOS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.34% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-2.05%
2. Health
2.1 Basic Checks
GKOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GKOS has been increased compared to 1 year ago.
Compared to 5 years ago, GKOS has more shares outstanding
Compared to 1 year ago, GKOS has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 12.52 indicates that GKOS is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 12.52, GKOS belongs to the best of the industry, outperforming 91.53% of the companies in the same industry.
A Debt/Equity ratio of 0.09 indicates that GKOS is not too dependend on debt financing.
GKOS has a better Debt to Equity ratio (0.09) than 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 12.52 |
ROIC/WACCN/A
WACC8.5%
2.3 Liquidity
GKOS has a Current Ratio of 5.51. This indicates that GKOS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.51, GKOS belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
A Quick Ratio of 4.69 indicates that GKOS has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.69, GKOS belongs to the best of the industry, outperforming 82.01% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.51 | ||
| Quick Ratio | 4.69 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 52.11% over the past year.
GKOS shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.38%.
GKOS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.10% yearly.
EPS 1Y (TTM)52.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)30.38%
Revenue growth 3Y9.26%
Revenue growth 5Y10.1%
Sales Q2Q%38.14%
3.2 Future
Based on estimates for the next years, GKOS will show a very strong growth in Earnings Per Share. The EPS will grow by 27.29% on average per year.
The Revenue is expected to grow by 28.17% on average over the next years. This is a very strong growth
EPS Next Y55.88%
EPS Next 2Y38.74%
EPS Next 3Y32.3%
EPS Next 5Y27.29%
Revenue Next Year29.93%
Revenue Next 2Y27.11%
Revenue Next 3Y26.92%
Revenue Next 5Y28.17%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
GKOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GKOS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
GKOS's earnings are expected to grow with 32.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.74%
EPS Next 3Y32.3%
5. Dividend
5.1 Amount
GKOS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
81.79
-2.56 (-3.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners107.33%
Inst Owner Change-0.05%
Ins Owners3.31%
Ins Owner Change0.63%
Market Cap4.69B
Revenue(TTM)469.82M
Net Income(TTM)-92.79M
Analysts83.64
Price Target120.44 (47.26%)
Short Float %4.34%
Short Ratio2.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.51%
Min EPS beat(2)11.08%
Max EPS beat(2)37.95%
EPS beat(4)3
Avg EPS beat(4)22.32%
Min EPS beat(4)-2.27%
Max EPS beat(4)42.53%
EPS beat(8)5
Avg EPS beat(8)8.64%
EPS beat(12)8
Avg EPS beat(12)7.63%
EPS beat(16)11
Avg EPS beat(16)4.11%
Revenue beat(2)2
Avg Revenue beat(2)3.68%
Min Revenue beat(2)2.01%
Max Revenue beat(2)5.35%
Revenue beat(4)4
Avg Revenue beat(4)3.41%
Min Revenue beat(4)2.01%
Max Revenue beat(4)5.35%
Revenue beat(8)8
Avg Revenue beat(8)3.55%
Revenue beat(12)12
Avg Revenue beat(12)3.87%
Revenue beat(16)16
Avg Revenue beat(16)4.23%
PT rev (1m)-4.39%
PT rev (3m)-5.03%
EPS NQ rev (1m)0.46%
EPS NQ rev (3m)-11.96%
EPS NY rev (1m)-0.25%
EPS NY rev (3m)-6.49%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)1.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 10.83 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 6.13 | ||
| P/tB | 10.96 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.02
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS7.55
BVpS13.34
TBVpS7.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.4% | ||
| ROE | -12.13% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 76.34% | ||
| FCFM | N/A |
ROA(3y)-13.08%
ROA(5y)-11.18%
ROE(3y)-22.32%
ROE(5y)-18.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-2.05%
F-Score5
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 55.95% | ||
| Cap/Sales | 5.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.51 | ||
| Quick Ratio | 4.69 | ||
| Altman-Z | 12.52 |
F-Score5
WACC8.5%
ROIC/WACCN/A
Cap/Depr(3y)54.99%
Cap/Depr(5y)69.95%
Cap/Sales(3y)6.26%
Cap/Sales(5y)7.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y55.88%
EPS Next 2Y38.74%
EPS Next 3Y32.3%
EPS Next 5Y27.29%
Revenue 1Y (TTM)30.38%
Revenue growth 3Y9.26%
Revenue growth 5Y10.1%
Sales Q2Q%38.14%
Revenue Next Year29.93%
Revenue Next 2Y27.11%
Revenue Next 3Y26.92%
Revenue Next 5Y28.17%
EBIT growth 1Y19.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year59.19%
EBIT Next 3Y45.08%
EBIT Next 5Y39.25%
FCF growth 1Y54.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.36%
OCF growth 3YN/A
OCF growth 5YN/A
GLAUKOS CORP / GKOS FAQ
Can you provide the ChartMill fundamental rating for GLAUKOS CORP?
ChartMill assigns a fundamental rating of 4 / 10 to GKOS.
What is the valuation status of GLAUKOS CORP (GKOS) stock?
ChartMill assigns a valuation rating of 1 / 10 to GLAUKOS CORP (GKOS). This can be considered as Overvalued.
How profitable is GLAUKOS CORP (GKOS) stock?
GLAUKOS CORP (GKOS) has a profitability rating of 2 / 10.
Can you provide the financial health for GKOS stock?
The financial health rating of GLAUKOS CORP (GKOS) is 6 / 10.
Can you provide the expected EPS growth for GKOS stock?
The Earnings per Share (EPS) of GLAUKOS CORP (GKOS) is expected to grow by 55.88% in the next year.